Veeva Systems announced the launch of Veeva EHS, a new application within Veeva Quality Cloud designed to help manufacturing and testing sites proactively identify, manage, and mitigate operational and environmental risks. The solution aims to ensure global compliance readiness through real-time insights and streamlined workflows. Scheduled for early adopter availability in August 2026, the application represents a shift toward intelligent automation in environmental, health, and safety management.

The application provides an intuitive interface for reporting safety incidents on the spot and managing investigations from start to finish. By connecting directly with Veeva QMS and Veeva Training, a safety event can automatically trigger a quality deviation and assign targeted retraining. This integration eliminates duplicate data entry and ensures compliance across the organization.

Bobbie Grant, global senior EHS manager at Thermo Fisher Scientific, emphasized the value of a unified data approach. "A modern EHS solution that simplifies processes through unified data and a seamless user experience across the entire EHS workflow can significantly improve site efficiency," Grant said. The solution is designed to maintain data integrity while providing a foundation for AI-driven capabilities to reduce risk over time.

Beth Tanner, vice president of Veeva EHS strategy, highlighted the operational benefits of the new system. "Delivering an advanced, automated approach to managing environmental, health, and safety processes, Veeva EHS will free up time for EHS teams and ensure quick and accurate execution," Tanner stated. Organizations replacing legacy systems with this unified platform will gain real-time transparency into leading indicators of risk for more informed decisions.

Key Features of Veeva EHS

Veeva Systems delivers industry cloud solutions for life sciences, serving more than 1,500 customers ranging from large pharmaceutical companies to emerging biotechs.

Veeva Systems announced it has acquired Copli, the pioneer in agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry. Copli is now available as Veeva Falcon MLR, an agentic MLR solution that significantly accelerates content review with the potential to eliminate 70% or more of manual MLR labor within five years. The acquisition terms were not disclosed. The strategic move aims to address the bottleneck in getting critical information to patients and doctors by speeding up the entire review cycle.

Veeva Falcon MLR brings agentic automation to marketing teams, MLR groups, and agencies. It executes rigorous reviews of promotional and medical materials, conducting compliance checks against approved labels and local regulations. This automation minimizes manual effort and allows reviewers to focus on higher value work.

Jacob Scheel-Bech, CEO of Copli, stated that the breakthrough with agentic MLR marks a fundamental shift in commercial and medical content review and approval. He noted that as part of Veeva, the company can scale its vision for MLR transformation, bringing compliance at speed to the industry with intelligent agents that work seamlessly with Veeva PromoMats.

Emma Hyland, vice president, Veeva Commercial Content, highlighted that the MLR process has long been a significant bottleneck. She explained that with Veeva Falcon MLR, customers can automate routine labor so reviewers can become strategic advisors.